Pepdox
Studies
Peptides
Calculator
Tirzepatide to treat obesity: phase III results. | Pepdox
Home
/
Search
/
PMID 35773392
Tirzepatide to treat obesity: phase III results.
Nature reviews. Gastroenterology & hepatology
2022
PMID: 35773392
View on PubMed
DOI: 10.1038/s41575-022-00657-z
Clinical Trial
Tirzepatide
Authors
Hindson, Jordan